Bioluminescent RIPoptosome Assay for FADD/RIPK1 Interaction Based on Split Luciferase Assay in a Human Neuroblastoma Cell Line SH-SY5Y

Different programed cell death (PCD) modalities involve protein–protein interactions in large complexes. Tumor necrosis factor α (TNFα) stimulated assembly of receptor-interacting protein kinase 1 (RIPK1)/Fas-associated death domain (FADD) interaction forms Ripoptosome complex that may cause either...

Full description

Bibliographic Details
Main Authors: Parisa Ghanavatian, Hossein Salehi-Sedeh, Farangis Ataei, Saman Hosseinkhani
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/13/2/297
_version_ 1827758277813862400
author Parisa Ghanavatian
Hossein Salehi-Sedeh
Farangis Ataei
Saman Hosseinkhani
author_facet Parisa Ghanavatian
Hossein Salehi-Sedeh
Farangis Ataei
Saman Hosseinkhani
author_sort Parisa Ghanavatian
collection DOAJ
description Different programed cell death (PCD) modalities involve protein–protein interactions in large complexes. Tumor necrosis factor α (TNFα) stimulated assembly of receptor-interacting protein kinase 1 (RIPK1)/Fas-associated death domain (FADD) interaction forms Ripoptosome complex that may cause either apoptosis or necroptosis. The present study addresses the interaction of RIPK1 and FADD in TNFα signaling by fusion of C-terminal (CLuc) and N-terminal (NLuc) luciferase fragments to RIPK1-CLuc (R1C) or FADD-NLuc (FN) in a caspase 8 negative neuroblastic SH-SY5Y cell line, respectively. In addition, based on our findings, an RIPK1 mutant (R1C K612R) had less interaction with FN, resulting in increasing cell viability. Moreover, presence of a caspase inhibitor (zVAD.fmk) increases luciferase activity compared to Smac mimetic BV6 (B), TNFα -induced (T) and non-induced cell. Furthermore, etoposide decreased luciferase activity, but dexamethasone was not effective in SH-SY5Y. This reporter assay might be used to evaluate basic aspects of this interaction as well as for screening of necroptosis and apoptosis targeting drugs with potential therapeutic application.
first_indexed 2024-03-11T09:05:28Z
format Article
id doaj.art-ec0b2c76470e4776bd82defc83ef9f1c
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-11T09:05:28Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-ec0b2c76470e4776bd82defc83ef9f1c2023-11-16T19:26:55ZengMDPI AGBiosensors2079-63742023-02-0113229710.3390/bios13020297Bioluminescent RIPoptosome Assay for FADD/RIPK1 Interaction Based on Split Luciferase Assay in a Human Neuroblastoma Cell Line SH-SY5YParisa Ghanavatian0Hossein Salehi-Sedeh1Farangis Ataei2Saman Hosseinkhani3Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14115-175, IranDepartment of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14115-175, IranDepartment of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14115-175, IranDepartment of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran 14115-175, IranDifferent programed cell death (PCD) modalities involve protein–protein interactions in large complexes. Tumor necrosis factor α (TNFα) stimulated assembly of receptor-interacting protein kinase 1 (RIPK1)/Fas-associated death domain (FADD) interaction forms Ripoptosome complex that may cause either apoptosis or necroptosis. The present study addresses the interaction of RIPK1 and FADD in TNFα signaling by fusion of C-terminal (CLuc) and N-terminal (NLuc) luciferase fragments to RIPK1-CLuc (R1C) or FADD-NLuc (FN) in a caspase 8 negative neuroblastic SH-SY5Y cell line, respectively. In addition, based on our findings, an RIPK1 mutant (R1C K612R) had less interaction with FN, resulting in increasing cell viability. Moreover, presence of a caspase inhibitor (zVAD.fmk) increases luciferase activity compared to Smac mimetic BV6 (B), TNFα -induced (T) and non-induced cell. Furthermore, etoposide decreased luciferase activity, but dexamethasone was not effective in SH-SY5Y. This reporter assay might be used to evaluate basic aspects of this interaction as well as for screening of necroptosis and apoptosis targeting drugs with potential therapeutic application.https://www.mdpi.com/2079-6374/13/2/297split luciferaseFADD/RIPK1 interactionRIPoptosomeSH-SY5Y cellsnecroptosis
spellingShingle Parisa Ghanavatian
Hossein Salehi-Sedeh
Farangis Ataei
Saman Hosseinkhani
Bioluminescent RIPoptosome Assay for FADD/RIPK1 Interaction Based on Split Luciferase Assay in a Human Neuroblastoma Cell Line SH-SY5Y
Biosensors
split luciferase
FADD/RIPK1 interaction
RIPoptosome
SH-SY5Y cells
necroptosis
title Bioluminescent RIPoptosome Assay for FADD/RIPK1 Interaction Based on Split Luciferase Assay in a Human Neuroblastoma Cell Line SH-SY5Y
title_full Bioluminescent RIPoptosome Assay for FADD/RIPK1 Interaction Based on Split Luciferase Assay in a Human Neuroblastoma Cell Line SH-SY5Y
title_fullStr Bioluminescent RIPoptosome Assay for FADD/RIPK1 Interaction Based on Split Luciferase Assay in a Human Neuroblastoma Cell Line SH-SY5Y
title_full_unstemmed Bioluminescent RIPoptosome Assay for FADD/RIPK1 Interaction Based on Split Luciferase Assay in a Human Neuroblastoma Cell Line SH-SY5Y
title_short Bioluminescent RIPoptosome Assay for FADD/RIPK1 Interaction Based on Split Luciferase Assay in a Human Neuroblastoma Cell Line SH-SY5Y
title_sort bioluminescent ripoptosome assay for fadd ripk1 interaction based on split luciferase assay in a human neuroblastoma cell line sh sy5y
topic split luciferase
FADD/RIPK1 interaction
RIPoptosome
SH-SY5Y cells
necroptosis
url https://www.mdpi.com/2079-6374/13/2/297
work_keys_str_mv AT parisaghanavatian bioluminescentripoptosomeassayforfaddripk1interactionbasedonsplitluciferaseassayinahumanneuroblastomacelllineshsy5y
AT hosseinsalehisedeh bioluminescentripoptosomeassayforfaddripk1interactionbasedonsplitluciferaseassayinahumanneuroblastomacelllineshsy5y
AT farangisataei bioluminescentripoptosomeassayforfaddripk1interactionbasedonsplitluciferaseassayinahumanneuroblastomacelllineshsy5y
AT samanhosseinkhani bioluminescentripoptosomeassayforfaddripk1interactionbasedonsplitluciferaseassayinahumanneuroblastomacelllineshsy5y